Severe #COVID19 induces an endotheliitis: a pseudo-vasculitis phenotype with a viral renal-lung syndrome and ARDS. Nephrologists report AKI without shock/renal hypoperfusion. Microvascular endotheliitis also explains cardiac manifestations & thrombosis
Whether the renovascular injury is primary or secondary to parenchymal injury is, however, unclear. The renal pathology shows more than simple endotheliitis with virus seen in renal tubules and podocytes as well as microthrombi.
The view of severe #COVID19 as a pseudo-vasculitis explains why those pre-primed by vascular risk factors (DM, HT etc) are prone to lethal complications. Vascular risk factors produce endothelial dysfunction and promote microvesicular tissue factor driven thromboinflammation
We know that ANCA vasculitis induced immunothrombosis with a resultant increase in the rate of both venous and arterial thrombosis. The endotheliitis we are seeing in #COVID19 might produce a rapidly progressive virally driven version of the same thing
As viral infiltration into cells is the driver of this pseudo-vasculitis we should be wary of thinking that immunosuppressive treatments for primary immunogenic vasculitis will help. It's catch-22. Any immunosuppressive drug eg Il-6 inhibitors may exacerbate the primary infection
You can follow @ToshiAkima.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: